Log on / register
Feedback | Support | My details
Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias.
Jeeninga RE, Jan B, van den Berg H, Berkhout B
Retrovirology 2006, 3:64
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%


 Research    
Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation
Vrolijk MM, Harwig A, Berkhout B, Das AT
Retrovirology 2009, 6:13 (11 February 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.
36%36%


 Editorial    
The 2008 Retrovirology Prize: Ben Berkhout and his RNA world
Jeang KT
Retrovirology 2008, 5:113 (11 December 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.
36%36%


 Research    
HIV-1 latency in actively dividing human T cell lines
Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B
Retrovirology 2008, 5:37 (25 April 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.
36%36%


 Research    
Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents
Mosca JD, Chang YN, Williams G
Retrovirology 2007, 4:32 (15 May 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
5.
36%36%


 Research    
Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control
Zhou X, Vink M, Berkhout B, Das AT
Retrovirology 2006, 3:82 (9 November 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.